Religare Enterprises (RELIGARE) | Financial Analysis & Statements
Religare Enterprises Ltd. Mid-cap Financial Services
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
20.4B
Gross Profit
13.5B
66.29%
Operating Income
-1.1B
-5.17%
Net Income
-765.4M
-3.75%
EPS (Diluted)
₹-1.37
Balance Sheet Metrics
Total Assets
112.3B
Total Liabilities
77.9B
Shareholders Equity
34.4B
Debt to Equity
2.27
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Religare Enterprises Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 9.4B | 47.7B | 37.3B | 24.5B | 16.8B |
| Cost of Goods Sold | 24.5B | - | - | - | - |
| Gross Profit | -15.2B | - | - | - | - |
| Gross Margin % | -161.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 2.1B | 2.6B | - | 3.8B | 2.5B |
| Other Operating Expenses | 42.9B | 1.6B | 28.4B | 22.3B | 2.3B |
| Total Operating Expenses | 45.0B | 4.2B | 28.4B | 26.1B | 4.8B |
| Operating Income | 2.8B | - | - | - | - |
| Operating Margin % | 29.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | 654.4M | - | - | - | - |
| Interest Expense | 352.4M | - | - | - | - |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 2.4B | 4.5B | 32.6B | -10.3B | -5.0B |
| Income Tax | 599.8M | 1.0B | 900.2M | 5.1B | -196.4M |
| Effective Tax Rate % | 24.7% | 22.4% | 2.8% | 0.0% | 0.0% |
| Net Income | 1.8B | 3.5B | 31.7B | -15.4B | -4.8B |
| Net Margin % | 19.5% | 7.3% | 85.1% | -62.8% | -28.4% |
| Key Metrics | |||||
| EBITDA | 3.3B | - | - | - | - |
| EPS (Basic) | ₹3.79 | ₹7.13 | ₹96.06 | ₹-51.33 | ₹-19.65 |
| EPS (Diluted) | ₹3.78 | ₹7.07 | ₹94.67 | ₹-51.33 | ₹-19.69 |
| Basic Shares Outstanding | 330322219 | 326706819 | 320808474 | 300770836 | 258748947 |
| Diluted Shares Outstanding | 330322219 | 326706819 | 320808474 | 300770836 | 258748947 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Religare Enterprises Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 3.0B | 4.3B | 8.1B | 25.3B | 8.3B |
| Short-term Investments | 17.8B | - | - | - | - |
| Accounts Receivable | 849.0M | - | - | - | - |
| Inventory | 28.2M | - | - | - | - |
| Other Current Assets | 2.8B | - | - | - | - |
| Total Current Assets | 26.7B | - | - | - | - |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.1B | 76.8M | 1.5B | 43.4M | 40.4M |
| Goodwill | 461.5M | 574.5M | 599.3M | 623.3M | 688.7M |
| Intangible Assets | 267.1M | 340.2M | 404.9M | 428.9M | 494.3M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 202.0M | - | - | - | - |
| Total Non-Current Assets | 85.6B | - | - | - | - |
| Total Assets | 112.3B | 95.8B | - | - | - |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 14.4B | 8.2B | 3.2B | 18.8B | 11.3B |
| Short-term Debt | 1.6B | - | - | - | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 8.9B | - | - | - | - |
| Total Current Liabilities | 75.8B | - | - | - | - |
| Non-Current Liabilities | |||||
| Long-term Debt | 746.7M | 4.4B | 8.4B | 47.9B | 48.6B |
| Deferred Tax Liabilities | 0 | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 2.1B | - | - | - | - |
| Total Liabilities | 77.9B | 64.0B | - | - | - |
| Equity | |||||
| Common Stock | 3.3B | 3.3B | 3.2B | 3.2B | 2.6B |
| Retained Earnings | -40.3B | -41.4B | - | -67.6B | -53.8B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 34.4B | 31.7B | 26.8B | -5.3B | 3.0B |
| Key Metrics | |||||
| Total Debt | 2.3B | 4.4B | 8.4B | 47.9B | 48.6B |
| Working Capital | -49.2B | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Religare Enterprises Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.4B | 4.5B | 32.6B | -10.3B | -5.0B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 909.0K | -7.3M | -50.3M | 45.1M | -63.7M |
| Working Capital Changes | 11.1B | 253.9M | 1.2B | 1.4B | -764.7M |
| Operating Cash Flow | 8.7B | -1.7B | 3.4B | -3.9B | -625.9M |
| Investing Activities | |||||
| Capital Expenditures | -245.6M | -210.4M | -396.6M | -390.0M | -177.3M |
| Acquisitions | 0 | -30.0M | 0 | 0 | 0 |
| Investment Purchases | -27.4B | -22.8B | -23.2B | -19.5B | -24.8B |
| Investment Sales | 9.4B | 7.3B | 9.8B | 12.8B | 13.2B |
| Investing Cash Flow | -17.4B | -18.4B | -12.8B | -9.2B | -13.6B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | 0 | 150.0M |
| Debt Repayment | - | - | -21.3B | -635.4M | -4.7B |
| Financing Cash Flow | 108.4M | 1.6B | -20.1B | 6.7B | -439.7M |
| Free Cash Flow | 15.5B | 14.8B | 14.7B | 15.6B | 13.5B |
| Net Change in Cash | -8.6B | -18.5B | -29.5B | -6.3B | -14.7B |
Cash Flow Trend
Religare Enterprises Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
70.89
Price to Book
2.52
Price to Sales
0.91
PEG Ratio
13.17
Profitability Ratios
Profit Margin
1.28%
Operating Margin
-4.55%
Return on Equity
3.64%
Return on Assets
1.11%
Financial Health
Current Ratio
1.00
Debt to Equity
8.07
Beta
-0.53
Per Share Data
EPS (TTM)
₹3.11
Book Value per Share
₹87.55
Revenue per Share
₹238.57
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| RELIGARE | 73.5B | 70.89 | 2.52 | 3.64% | 1.28% | 8.07 |
| Life Insurance | 5.2T | 9.83 | 4.28 | 37.90% | 5.97% | 0.00 |
| SBI Life Insurance | 1.8T | 74.04 | 9.64 | 13.70% | 2.20% | 0.00 |
| Niva Bupa Health | 149.1B | 154.02 | 4.18 | 7.96% | 3.66% | 7.30 |
| HDFC Life Insurance | 1.3T | 67.42 | 7.26 | 11.28% | 1.92% | 17.46 |
| ICICI Prudential | 775.6B | 48.61 | 5.74 | 12.58% | 2.53% | 19.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





